Acepodia, Inc. (6976)
TWSE
Closed
Oct 8, 2026
Day's Range
13.2052 wk Range
10.85Overview - 6976 - Acepodia, Inc.
Key Statistics
Valuation
Enterprise Value
4.25B
P/E (Trailing)
‪61.21‬
Price / Sales (TTM)
‪40,328.10‬
Price / Book
‪1.47‬
EV / EBITDA
‪-4.48‬
Profitability
Profit Margin
‪65.40%‬
Operating Margin
‪-409,336.21%‬
Return on Assets
‪-11.35%‬
Return on Equity
‪-15.77%‬
Ownership
Shares Outstanding
582.86M
Float
298.22M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.03%‬
Price stats
Beta
‪0.51‬
50-Day Avg
‪12.32‬
200-Day Avg
‪13.03‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 6976 - Acepodia, Inc.
Peers - 6976 - Acepodia, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
Profile Summary - 6976 - Acepodia, Inc.
About
Acepodia, Inc. is a clinical-stage biotechnology company specializing in pioneering cell therapies aimed at transforming cancer treatment. The company's primary focus lies in its proprietary Antibody-Cell Conjugation (ACC) platform, a technology that directly links tumor-targeting antibodies to immune cells such as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
